View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB16 | Publication ID: Spring 2009 |
Title: Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance | |
Abstract: The Drug Enforcement Administration is designating the precursor chemical, 4-anilino-N-phenethyl-4-piperidine (ANPP) as an immediate precursor for the Schedule II controlled substance, fentanyl. Further, DEA is controlling ANPP as a Schedule II controlled substance under the Controlled Substances Act. ANPP is the immediate chemical intermediary in the synthesis process currently used by clandestine laboratory operators for the illicit manufacture of the Schedule II controlled substance fentanyl. | |
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1308 | |
Legal Authority: 21 USC 811 21 USC 812 21 USC 871(b) |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Additional Information: Docket No. DEA-305 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Information URL: www.regulations.gov | Public Comment URL: www.deadiversion.usdoj.gov |
RIN Data Printed in the FR: No | |
Agency Contact: Christine A. Sannerud Ph.D. Chief, Drug and Chemical Evaluation Section, Office of Diversion Control Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Washington, DC 20537 Phone:202 307-7183 |